NextCure

is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer...
Read more
NextCure President & CEO: Michael Richman

President & CEO

Michael Richman

CEO Approval Rating

48/100

Annual Revenue
$48.3M
Employees
90
Funding
$160.4M

NextCure Competitors

1NexImmune
2Silverback Therapeutics
3Aura
4AstraZeneca
5Daiichi Sankyo
6bluebird bio
7Bristol-Myers Squibb
8ImmunityBio
9Byondis
10Mustang Bio

Trending Companies